Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 22.52 Delayed Data As of May 26 |  +0.14 / +0.63%Today’s Change | 14.89 Today|||52-Week Range 30.22 | -2.93% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -27.3M | -94.2M | -74.9M | -39.1M | |
| Depreciation | 171.0K | 655.0K | 594.0K | 110.9M | ||
| Total Other Cash Flow | 2.2M | 5.8M | 9.8M | 33.1M | ||
| Funds From Operations | -24.9M | -87.8M | -64.5M | 104.8M | ||
| Funds From/For Other Operating Expenses | -3.3M | -12.7M | 2.5M | -64.6M | ||
| Net Cash Flow - Operating Activities | -21.6M | -75.1M | -67.0M | 169.4M | ||
| Investing | Capital Expenditures | -362.0K | -477.0K | -990.0K | -5.5M | |
| Net Cash Flow Investing | -362.0K | -3.0M | -990.0K | -24.4M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 10.0M | ||
| Long Term Debt Reduction | -1.3M | -2.7M | -2.7M | 0.00 | ||
| Net Proceeds Stock Sale | 117.4M | 138.2M | 36.2M | 5.3M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 16.0K | 0.00 | 68.0K | 132.6M | ||
| Net Cash Flow - Financing | 116.0M | 135.6M | 33.5M | -117.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 94.1M | 57.5M | -34.5M | 27.8M | ||
